Viracta Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
Viracta Therapeutics announced participation in the 20th Annual Needham Virtual Healthcare Conference from April 12-15, 2021. The Company will present on April 14, 2021, at 3:45 PM ET, focusing on its precision oncology efforts targeting virus-associated malignancies. Viracta's investigational drug, nanatinostat, is in a Phase 2 trial for EBV-positive lymphoma, combined with valganciclovir, and is exploring applications for other EBV-related cancers. For more details, visit www.viracta.com.
- None.
- None.
SAN DIEGO, April 8, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that Company management will present at the 20th Annual Needham Virtual Healthcare Conference taking place April 12-15, 2021. The Company will also participate in one-on-one investor meetings at the conference.
Details on the presentation can be found below.
Date: | Wednesday, April 14, 2021 |
Time: | 3:45 PM ET |
Format: | Corporate presentation |
About Viracta Therapeutics, Inc.
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphoma. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
For additional information please visit www.viracta.com.
Investor Relations Contact: | Company Contact: |
Joyce Allaire | Dan Chevallard |
LifeSci Advisors | Chief Operating Officer and Chief Financial Officer |
(212) 915-2569 | (858) 771-4193 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/viracta-therapeutics-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-301264794.html
SOURCE Viracta
FAQ
What is Viracta's presentation date at the Needham Virtual Healthcare Conference?
What time will Viracta present at the conference?
What is Viracta's focus in oncology?
What drug is Viracta currently evaluating in clinical trials?
What other cancers is Viracta targeting with its therapies?
